Ghafori SS, Yousefi Z, Bakhtiari E, Hassanzadeh G (2024) Neutrophil-to-lymphocyte ratio as a predictive biomarker for early diagnosis of depression: a narrative review. Brain, Behavior, Immun-Health 36:100734

Article  CAS  Google Scholar 

Chen S, Sun H, Song Y, Zhang M, Huang W, Zhao C et al (2024) Transition and trend analysis of the burden of depression in China and different income countries: based on GBD database and joinpoint regression model. J Affect Disord. https://doi.org/10.1016/j.jad.2024.06.067

Article  PubMed  PubMed Central  Google Scholar 

Campbell S, Macqueen G (2004) The role of the hippocampus in the pathophysiology of major depression. J Psychiatry Neurosci 29(6):417–426

Article  PubMed  PubMed Central  Google Scholar 

Liang J, Chen L, Li Y, Chen Y, Yuan L, Qiu Y et al (2024) Unraveling the prefrontal cortex-basolateral amygdala pathway’s role on schizophrenia’s cognitive impairments: a multimodal study in patients and mouse models. Schizophr Bull 50(4):913–923

Article  PubMed  PubMed Central  Google Scholar 

Wan L, Pei P, Zhang Q, Gao W (2024) Specificity in the commonalities of inhibition control: using meta-analysis and regression analysis to identify the key brain regions in psychiatric disorders. Eur Psychiatry 67(1):e69

Article  PubMed  PubMed Central  Google Scholar 

Sheline YI (2011) Depression and the hippocampus: cause or effect? Biol Psychiatry 70(4):308–309

Article  PubMed  PubMed Central  Google Scholar 

Mokhtari T, Tu Y, Hu L (2019) Involvement of the hippocampus in chronic pain and depression. Brain Sci Adv 5(4):288–298

Article  Google Scholar 

Luo F, Liu L, Guo M, Liang J, Chen L, Shi X et al (2024) Deciphering and targeting the ESR2–miR-10a-5p–BDNF axis in the prefrontal cortex: advancing postpartum depression understanding and therapeutics. Research 7:0537

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cui L, Li S, Wang S, Wu X, Liu Y, Yu W et al (2024) Major depressive disorder: hypothesis, mechanism, prevention and treatment. Signal Transduct Target Ther 9(1):30

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen Y, Yin P, Chen Q, Zhang Y, Tang Y, Jin W, Yu L (2025) Neurodegenerative diseases and immune system: From pathogenic mechanism to therapy. Neural Regen Res 1:1–29

Mokhtari T, Uludag K (2023) Role of NLRP3 inflammasome in post-spinal-cord-injury anxiety and depression: molecular mechanisms and therapeutic implications. ACS Chem Neurosci 15(1):56–70

Article  PubMed  Google Scholar 

Mokhtari T, Lu M, El-Kenawy AE-M (2023) Potential anxiolytic and antidepressant-like effects of luteolin in a chronic constriction injury rat model of neuropathic pain: role of oxidative stress, neurotrophins, and inflammatory factors. Int Immunopharmacol 122:110520

Article  CAS  PubMed  Google Scholar 

Amini M, Yousefi Z, Ghafori SS, Hassanzadeh G (2022) Sleep deprivation and NLRP3 inflammasome: is there a causal relationship? Front Neurosci 16:1018628

Article  PubMed  PubMed Central  Google Scholar 

Gholaminejhad M, Jameie SB, Abdi M, Abolhassani F, Mohammed I, Hassanzadeh G (2022) All-trans retinoic acid-preconditioned mesenchymal stem cells improve motor function and alleviate tissue damage after spinal cord injury by inhibition of HMGB1/NF-κB/NLRP3 pathway through autophagy activation. J Mol Neurosci 72(5):947–962

Article  CAS  PubMed  Google Scholar 

Gholaminejhad M, Forouzesh M, Ebrahimi B, Mahdavi SA, Mirtorabi SD, Liaghat A et al (2022) Formation and activity of NLRP3 inflammasome and histopathological changes in the lung of corpses with COVID-19. J Mol Histol 53(6):883–890

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yarahmadi A, Malek F, Poorhassan M, Ghaffari N, Ebrahimi B, Bazrafkan M et al (2022) Curcumin attenuates development of depressive-like behavior in male rats after spinal cord injury: involvement of NLRP3 inflammasome. J Contemp Med Sci 8(3): 176–183

Das R, Emon MPZ, Shahriar M, Nahar Z, Islam SMA, Bhuiyan MA et al (2021) Higher levels of serum IL-1β and TNF-α are associated with an increased probability of major depressive disorder. Psychiatr Res 295:113568

Article  CAS  Google Scholar 

Zhang Y, Liu L, Liu Y-Z, Shen X-L, Wu T-Y, Zhang T et al (2015) Nlrp3 inflammasome mediates chronic mild stress-induced depression in mice via neuroinflammation. Int J Neuropsychopharmacol 18(8):pyv006

Article  PubMed  PubMed Central  Google Scholar 

Karrouri R, Hammani Z, Benjelloun R, Otheman Y (2021) Major depressive disorder: validated treatments and future challenges. World J Clin Cases 9(31):9350

Article  PubMed  PubMed Central  Google Scholar 

Marwaha S, Palmer E, Suppes T, Cons E, Young AH, Upthegrove R (2023) Novel and emerging treatments for major depression. Lancet 401(10371):141–153

Article  CAS  PubMed  Google Scholar 

Ezawa ID, Robinson N, Hollon SD (2024) Prevalence increases as treatments improve: an evolutionary perspective on the treatment–prevalence paradox in depression. Annu Rev Clin Psychol 20(1):201–228

Article  PubMed  Google Scholar 

Sadr S, Ahmadi Simab P, Niazi M, Yousefsani Z, Lotfalizadeh N, Hajjafari A et al (2024) Anti-inflammatory and immunomodulatory effects of mesenchymal stem cell therapy on parasitic drug resistance. Expert Rev Anti Infect Ther 22(6):435–451

Pharoun J, Berro J, Sobh J, Abou-Younes M-M, Nasr L, Majed A et al (2024) Mesenchymal stem cells biological and biotechnological advances: implications for clinical applications. Eur J Pharmacol 977:176719

Article  CAS  PubMed  Google Scholar 

Asgari Taei A, Nasoohi S, Hassanzadeh G, Kadivar M, Dargahi L, Farahmandfar M (2021) Enhancement of angiogenesis and neurogenesis by intracerebroventricular injection of secretome from human embryonic stem cell-derived mesenchymal stem cells in ischemic stroke model. Biomed Pharmacother 140:111709

Article  CAS  PubMed  Google Scholar 

Tfilin M, Sudai E, Merenlender A, Gispan I, Yadid G, Turgeman G (2010) Mesenchymal stem cells increase hippocampal neurogenesis and counteract depressive-like behavior. Mol Psychiatry 15(12):1164–1175

Article  CAS  PubMed  Google Scholar 

Kin K, Yasuhara T, Borlongan CV, Date I (2018) Encapsulated stem cells ameliorate depressive-like behavior via growth factor secretion. Brain Circ 4(3):128–132

Article  PubMed  PubMed Central  Google Scholar 

Wang P, Li Y, Song Y, Gao Y, Hao C, Zhou Y et al (2024) Human umbilical cord mesenchymal stem cells reverse depression in rats induced by chronic unpredictable mild stress combined with lipopolysaccharide. CNS Neurosci Ther 30(3):e14644

Article  CAS  PubMed  PubMed Central  Google Scholar 

Huang J, Huang W, Yi J, Deng Y, Li R, Chen J et al (2023) Mesenchymal stromal cells alleviate depressive and anxiety-like behaviors via a lung vagal-to-brain axis in male mice. Nat Commun 14(1):7406

Article  PubMed  PubMed Central  Google Scholar 

Shwartz A, Betzer O, Kronfeld N, Kazimirsky G, Cazacu S, Finniss S et al (2017) Therapeutic effect of astroglia-like mesenchymal stem cells expressing glutamate transporter in a genetic rat model of depression. Theranostics 7(10):2690–2703

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li J, Tian S, Wang H, Du C, Fang J, Wang X et al (2021) Protection of hUC-MSCs against neuronal complement C3a receptor-mediated NLRP3 activation in CUMS-induced mice. Neurosci Lett 741:135485

Article  CAS  PubMed  Google Scholar 

Ju R, Gao X, Zhang C, Tang W, Tian W, He M (2024) Exogenous MSCs based tissue regeneration: a review of immuno-protection strategies from biomaterial scaffolds. J Mater Chem B. https://doi.org/10.1039/D4TB00778F

Article  PubMed  Google Scholar 

Kazemi A, Eshkoor PA, Saeedi P, Halabian R (2022) Evaluation of antioxidant and antibacterial effects of lactobacilli metabolites-preconditioned bone marrow mesenchymal stem cells in skin lesions amelioration. Bioorg Chem 124:105797

Article  CAS  PubMed  Google Scholar 

Mendi A, Aktaş B, Aslım B (2022) Mesenchymal stem cell-probiotic communication: beneficial bacteria in preconditioning. Springer, Handbook of Stem Cell Therapy, pp 1–20